Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.7 0 (0%) Market Cap: 2.45 Bil Enterprise Value: 4.93 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 62/100

Amneal Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2022 / 04:15PM GMT
Release Date Price: €4.12 (+1.48%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. I'm Chris Schott at JPMorgan, and it is my pleasure to be introducing Amneal today at the 40th Annual JPMorgan Healthcare Conference. Now, from the company, we have the Founder and Co-CEO, Chirag Patel. (Operator Instructions)

And with that, Chirag, Happy New Year. Thanks for joining us, and I look forward to your comments.

Chirag K. Patel
Amneal Pharmaceuticals, Inc. - Co-Founder, Co-CEO, President & Director

Thank you, Chris. Good to see you via Zoom and hopefully, we'll be back live next year. Thank you, everyone, for joining us today.

A brief introduction, my brother and I humbly started the company in Paterson, New Jersey back in 2002, and have grown to be the fourth largest, I call it, affordable medicine company in the United States. We're very fortunate to have a great team of Amnealians, which has made this possible. And today, I'm going to discuss the strategy for the company's growth in upcoming years, from now to 5

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot